Sign in

CIK 0001400118 · <br>Emerging growth company

Sagimet Biosciences Inc.

Sign in to watch
Ticker
SGMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205991472
Phone
(650) 561-8600
Business address
950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
Former names
3-V Biosciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-14 Kemble George Director Option exercise 10b5-1 +326,618 $6.36 $2.1M 388,779
2026-08-14 Kemble George Director Option exercise 10b5-1 +24,369 $6.36 $155K 413,148
2026-08-14 Kemble George Director Sale 10b5-1 −350,987 $10.23 $3.6M 62,161
2026-08-14 Kemble George Director Option exercise · Stock Option (Right to Buy) 10b5-1 −326,618 31,455
2026-08-14 Kemble George Director Option exercise · Stock Option (Right to Buy) 10b5-1 −24,369 11,608
2026-08-11 Kemble George Director Option exercise 10b5-1 +9,751 $6.36 $62K 71,912
2026-08-11 Kemble George Director Option exercise 10b5-1 +10,455 $6.36 $66K 82,367
2026-08-11 Kemble George Director Sale 10b5-1 −20,206 $9.95 $201K 62,161
2026-08-11 Kemble George Director Option exercise · Stock Option (Right to Buy) 10b5-1 −9,751 358,073
2026-08-11 Kemble George Director Option exercise · Stock Option (Right to Buy) 10b5-1 −10,455 35,977
2026-07-20 Happel David President & CEO Sale −64,051 $7.76 $497K 741,570
2026-07-20 Rozek Elizabeth Chief Legal & Admin. Officer Sale −10,545 $7.76 $82K 224,414
2026-07-20 Kemble George Director Sale 10b5-1 −18,844 $7.46 $141K 62,161
2026-06-12 SEIDENBERG BETH C Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 Hoelscher Paul W. Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 Jarrett Jennifer Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 GRAMMER ELIZABETH A Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 Kemble George Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 Phillips Anne M. Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-05-28 Chauche Thierry Chief Financial Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000

Page 1 of 10 · 194 trades